Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340701 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of Progesterone in Pregnancy
A Phase 1 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03340701: Completed Phase 1 study, sponsored by Thomas Jefferson University.
NCT03340701 is a Phase 1 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03340701, a Phase 1 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
Pharmacokinetic analysis of 200mg vaginal progesterone suppository in women with singleton pregnancies between 18 0/7- 23 6/7 weeks' gestation
Primary Outcome
Plasma concentration time profile of vaginal progesterone in pregnant women.
Interventions
- DRUG vaginal progesterone suppository
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2018-06-30 |
| Phase | Phase 1 |
What the finished NCT03340701 record still lists
NCT03340701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which vaginal progesterone suppository is the first listed.
NCT03340701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03340701 about?
NCT03340701 is a clinical study titled "Pharmacokinetics of Progesterone in Pregnancy". Pharmacokinetic analysis of 200mg vaginal progesterone suppository in women with singleton pregnancies between 18 0/7- 23 6/7 weeks' gestation
What is the current status of trial NCT03340701?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-11-06. Estimated completion is 2018-06-30.
What interventions are being tested in trial NCT03340701?
The interventions under investigation include: vaginal progesterone suppository (DRUG).
Who is sponsoring clinical trial NCT03340701?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03340701's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI